EBONY SLAUGHTER-JOHNSON — Lobbyist Profile | Poliscope

EBONY SLAUGHTER-JOHNSON

Filings

Clients

Firms

Years active

2026–2026

Associated filing income

$120,000

How to read the money

Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.

Clients represented

Client	Filings	Years
SICK CELLS	3	2026
ALL* ABOVE ALL	2	2026
AMERICAN HEALTHY ALTERNATIVES ASSOCIATION	1	2026

Lobbying firms

Firm	Filings	Years
INDIGO HILL STRATEGIES	6	2026

Bills explicitly cited in this lobbyist’s assigned issues (32)

No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.

H.R. 1796

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 1796

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Original LDA source filings (6)

Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.

ALL* ABOVE ALL via INDIGO HILL STRATEGIES

2026 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Assigned issues and filing targets (1 issues)

HCR

Health Issues

Issues related to Abortion Access; H.R.4611/ S. 2377 - EACH Act of 2025

Filing targets: HOUSE OF REPRESENTATIVES, SENATE

SICK CELLS via INDIGO HILL STRATEGIES

2026 · third_quarter · Q3

Firm income: $30,000Client expense: —Open original LDA filing ↗

Source: Senate LDA

Show 28 more cited filings

H.R. 1796

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 1796

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 4611

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to Abortion Access; H.R.4611/ S. 2377 - EACH Act of 2025

H.R. 4611

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to abortion coverage; Issues related to H.R. 4611/S. 2377 - EACH Act of 2025.

H.R. 4611

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to abortion coverage; Issues related to H.R. 4611/S. 2377 - EACH Act of 2025.

H.R. 4611

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to abortion coverage; Issues related to H.R. 4611/S. 2377 - EACH Act of 2025.

H.R. 5178

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 5178

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 5178

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 5178

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 5178

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

H.R. 5178

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 2377

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to Abortion Access; H.R.4611/ S. 2377 - EACH Act of 2025

S. 2377

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to abortion coverage; Issues related to H.R. 4611/S. 2377 - EACH Act of 2025.

S. 2377

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to abortion coverage; Issues related to H.R. 4611/S. 2377 - EACH Act of 2025.

S. 2377

EACH Act of 2025

Client: ALL* ABOVE ALL · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Issues related to abortion coverage; Issues related to H.R. 4611/S. 2377 - EACH Act of 2025.

S. 721

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 721

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 721

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 721

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 721

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 721

Sickle Cell Disease Comprehensive Care Act

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 735

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 735

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 735

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 735

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 735

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

Labor/HHS Appropriations H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act

S. 735

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025

Client: SICK CELLS · Firm: INDIGO HILL STRATEGIES

Open original LDA filing ↗

Cited source text

H.R 1796/ S. 735 - Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2025 H.R. 5178/ S.721 - Sickle Cell Disease Comprehensive Care Act